Results 61 to 70 of about 21,166 (196)
Gut and LiverBackground/Aims: This study aimed to assess whether hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) could have favorable prognoses with proper treatment under selective conditions.
Young Chang +8 more
doaj +1 more source
대한영상의학회지, 2018 Bone metastasis is the third most common extrahepatic metastasis from hepatocellular carcinoma (HCC), following lung and lymph node metastasis. Although transcatheter arterial chemoembolization (TACE) is widely used for the treatment for unresectable HCC
Hye Ji Ryu, Sung Nam Moon, Nam Kyu Chang
doaj +1 more source
Lipiodol Embolism with Pneumonitis and ALI after TACE – A Case Report
National Board of Examinations Journal of Medical Sciences, 2023 Transcatheter arterial chemoembolization (TACE) is a useful palliative therapeutic modality for hepatocellular carcinoma (HCC) and has developed into a successful alternate therapeutic method for people with HCC that is inoperable.
Devendrappa K R +3 more
doaj +1 more source
Chinese Medical Journal, 2017 Background: Liver abscess is a serious complication following transcatheter arterial chemoembolization (TACE). Much attention has been paid to this condition as it may interfere with the treatment process and result in a poor prognosis of the patient ...
Wei Sun, Fei Xu, Xiao Li, Chen-Rui Li
doaj +1 more source
High-intensity focused ultrasound for hepatocellular carcinoma: A single-center experience [PDF]
, 2011 Objective: This study aims to evaluate the outcome of patients with hepatocellular carcinoma (HCC) treated by high-intensity focused ultrasound (HIFU) in a single tertiary referral center. Background: HIFU is the latest developed local ablation technique
Chan, SC +10 more
core +1 more source
Gut and LiverBackground/Aims: Local ablation therapy (LAT) is primarily recommended for solitary inoperable hepatocellular carcinomas (HCCs) of ≤3 cm in diameter. However, only two-thirds of uninodular small HCCs are suitable for LAT, and the second-best treatment ...
Jihye Lim +6 more
doaj +1 more source
Clinics, 2015 OBJECTIVE: Transarterial chemoembolization is the treatment of choice for intermediate-stage hepatocellular carcinoma. However, there are no clear data supporting transarterial chemoembolization vs .
Lucas Moretti Monsignore +6 more
doaj +1 more source
[Chemoembolization and posterior liver transplantation as therapeutic strategy for hepatocarcinoma].
Revista espanola de enfermedades digestivas, 1994 Orthotopic Liver Transplantation (OLT) is the only surgical approach to non-resectable hepatocellular carcinoma (HCC) but, so far its results has been poor. During 41 months 112 patients underwent 123 OLT, nine of them had HCC over cirrhosis with a mean age 60 years. The etiology of cirrhosis was: alcohol in 1 and viral hepatitis in 8. Child's grade: A
M, Salcedo +9 more
openaire +1 more source
Imaging appearance of treated hepatocellular carcinoma. [PDF]
, 2013 Surgical resection and imaging guided treatments play a crucial role in the management of hepatocellular carcinoma (HCC). Although the primary end point of treatment of HCC is survival, radiological response could be a surrogate end point of survival ...
AGNELLO, Francesco +6 more
core +1 more source
Cancer Imaging, 2019 Background To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembolization (cTACE).
Marco Dioguardi Burgio +6 more
doaj +1 more source